Proposed acquisition could potentially add approximately $1.8 million (unaudited) revenue, increase Inspire's current locations in Florida to 5, and bring the total number of animal hospitals in its network to 14.
Read More
MedSmart Wellness Centers Inc. Signs Letter of Intent to Acquire 3,000 Sq. Ft. Facility in Tequesta, Florida
Read More
ComparisonAdviser, an online personal finance resource, releases its comprehensive ranking of top U.S. financial advisor firms based on key factors, such as services, fee structure, account minimums, and overall client satisfaction.
Read MoreQ4 revenue increases 31% to $3.1 million
4Q gross profit increases to $2.0 million, or 65% of total revenue
267% increase in 2024 shareholders’ equity compared to 2023
Company expanded Nova Ortho and Spine footprint and enhanced patient volume in 2024
Monogram May Market the Monogram mBôs™ TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act (the Act).
The Company is Preparing for Commercialization and Evaluating Strategies to Support the Adoption of its Robotic-Assisted Technology
Read MoreThe official World Record now stands at 200 million degrees Celsius, continuously held for 86,400 seconds. Finally, safe sustained Nuclear Fusion has arrived and can be deployed rapidly into any industry using Quantum Kinetics' Arc Reactor™ technology.
Read More
LaunchMyStore Earns Positive Recognition for Empowering Small Businesses and Dropshippers , An Accessible All-in-One Platform for Those Looking to Launch Online Businesses, Expand Dropshipping Ventures, and Operate Successful Online Ecommerce Website
Read More
The move consolidates operations and resources for 50 companies in 26 countries in the Building, Specifications, and Construction Industries. Hubexo aims to help construction professionals sell more, improve efficiency, and build more sustainably.
Read MoreJaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel syndrome with intestinal failure and microvillus inclusion disease
FDA meeting expected in Q2 2025 on the statistically significant results of the Phase 3 OnTarget trial of crofelemer in the prespecified subgroup of patients with breast cancer
Read More